Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Structure guided prediction of Pyrazinamide resistance mutations in pncA.

Karmakar M, Rodrigues CHM, Horan K, Denholm JT, Ascher DB.

Sci Rep. 2020 Feb 5;10(1):1875. doi: 10.1038/s41598-020-58635-x.

2.

Speaking up: language services, tuberculosis and human rights.

Denholm JT, Leontiou C, McKeown A, Watts KN, Pereira D.

Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1336. doi: 10.5588/ijtld.19.0400. No abstract available.

PMID:
31931919
3.

Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing.

Dunstan SJ, Williamson DA, Denholm JT.

Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1241-1242. doi: 10.5588/ijtld.19.0604. No abstract available.

PMID:
31931906
4.

Adolescent tuberculosis.

Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dodd PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K.

Lancet Child Adolesc Health. 2020 Jan;4(1):68-79. doi: 10.1016/S2352-4642(19)30337-2. Epub 2019 Nov 18. Review. Erratum in: Lancet Child Adolesc Health. 2019 Nov 27;:.

PMID:
31753806
5.

Hyper transmission of Beijing lineage Mycobacterium tuberculosis: Systematic review and meta-analysis.

Karmakar M, Trauer JM, Ascher DB, Denholm JT.

J Infect. 2019 Dec;79(6):572-581. doi: 10.1016/j.jinf.2019.09.016. Epub 2019 Oct 1.

PMID:
31585190
6.

Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.

Venkatesan S, Myles PR, Bolton KJ, Muthuri SG, Al Khuwaitir T, Anovadiya AP, Azziz-Baumgartner E, Bajjou T, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Chinbayar T, Cilloniz C, Denholm JT, Dominguez SR, Duarte PAD, Dubnov-Raz G, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hu XY, Islam QT, Jiménez MF, Keijzers G, Khalili H, Kusznierz G, Kuzman I, Langenegger E, Lankarani KB, Leo YS, Libster RP, Linko R, Madanat F, Maltezos E, Mamun A, Manabe T, Metan G, Mickiene A, Mikić D, Mohn KGI, Oliva ME, Ozkan M, Parekh D, Paul M, Rath BA, Refaey S, Rodríguez AH, Sertogullarindan B, Skręt-Magierło J, Somer A, Talarek E, Tang JW, To K, Tran D, Uyeki TM, Vaudry W, Vidmar T, Zarogoulidis P; PRIDE Consortium Investigators , Nguyen-Van-Tam JS.

J Infect Dis. 2020 Jan 14;221(3):356-366. doi: 10.1093/infdis/jiz152.

PMID:
31314899
7.

Explaining variation in the burden of child and adolescent tuberculosis.

Snow KJ, Sawyer SM, Denholm JT, Graham SM.

Eur Respir J. 2019 Jun 27;53(6). pii: 1901007. doi: 10.1183/13993003.01007-2019. Print 2019 Jun. No abstract available.

PMID:
31249013
8.

Estimating long-term tuberculosis reactivation rates in Australian migrants.

Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT.

Clin Infect Dis. 2019 Jun 27. pii: ciz569. doi: 10.1093/cid/ciz569. [Epub ahead of print]

PMID:
31246254
9.

Profiles of tuberculosis disease activation among contacts of patients with tuberculosis.

Melsew YA, Cheng AC, McBryde ES, Denholm JT, Tay E, Ragonnet R, Trauer JM.

Eur Respir J. 2019 Oct 10;54(4). pii: 1900353. doi: 10.1183/13993003.00353-2019. Print 2019 Oct. No abstract available.

PMID:
31164436
10.

The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracing.

Melsew YA, Gambhir M, Cheng AC, McBryde ES, Denholm JT, Tay EL, Trauer JM.

BMC Infect Dis. 2019 Mar 12;19(1):244. doi: 10.1186/s12879-019-3870-1.

11.

The role of geospatial hotspots in the spatial spread of tuberculosis in rural Ethiopia: a mathematical model.

Shaweno D, Trauer JM, Denholm JT, McBryde ES.

R Soc Open Sci. 2018 Sep 19;5(9):180887. doi: 10.1098/rsos.180887. eCollection 2018 Sep.

12.

Tuberculosis Elimination in the Asia-Pacific Region and the WHO Ethics Guidance.

Denholm JT, Silva DS, Burhan E, Chaisson RE.

Trop Med Infect Dis. 2018 Oct 31;3(4). pii: E115. doi: 10.3390/tropicalmed3040115.

13.

Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia.

Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT.

Eur Respir J. 2018 Dec 20;52(6). pii: 1801218. doi: 10.1183/13993003.01218-2018. Print 2018 Dec.

PMID:
30361251
14.

Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.

Shaweno D, Karmakar M, Alene KA, Ragonnet R, Clements AC, Trauer JM, Denholm JT, McBryde ES.

BMC Med. 2018 Oct 18;16(1):193. doi: 10.1186/s12916-018-1178-4.

15.

Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in Australia.

Cheung YM, Van K, Lan L, Barmanray R, Qian SY, Shi WY, Wong JLA, Hamblin PS, Colman PG, Topliss DJ, Denholm JT, Grossmann M.

Intern Med J. 2019 Mar;49(3):364-372. doi: 10.1111/imj.14085.

PMID:
30151969
16.

The Use of Fluoroquinolones for Tuberculosis in Victoria between 2011 and 2016.

Murray H, Tay EL, Dinh S, Matthews H, Street A, Denholm JT.

Tuberc Res Treat. 2018 Jul 2;2018:6860479. doi: 10.1155/2018/6860479. eCollection 2018.

17.

Pulmonary extensively drug-resistant tuberculosis in Melbourne: local control of a global health challenge.

Tramontana AR, Leslie DE, Nolan A, Globan M, Fyfe JM, Denholm JT, Guy SD.

Med J Aust. 2018 Jun 4;208(10):428-429. No abstract available.

PMID:
29848244
18.

Tuberculosis screening in an aged care residential facility in a low-incidence setting.

Moyo N, Trauer J, Trevan P, Baker AM, Musemburi J, McGrath K, Nolan A, McIntyre E, Hulls J, Denholm JT.

Commun Dis Intell Q Rep. 2017 Sep 1;41(3):E209-E211.

19.

Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.

Karmakar M, Globan M, Fyfe JAM, Stinear TP, Johnson PDR, Holmes NE, Denholm JT, Ascher DB.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):541-544. doi: 10.1164/rccm.201712-2572LE. No abstract available.

20.

Immortal Time Bias in Assessing Evidence-Based Care Processes for Staphylococcus aureus Bacteremia.

Tong SYC, Cheng AC, Denholm JT.

JAMA Intern Med. 2018 Feb 1;178(2):295-296. doi: 10.1001/jamainternmed.2017.7947. No abstract available.

PMID:
29404611
21.

SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.

Denholm JT, McBryde ES, Eisen D, Street A, Matchett E, Chen C, Shultz TR, Biggs B, Leder K.

Intern Med J. 2017 Dec;47(12):1433-1436. doi: 10.1111/imj.13601. Erratum in: Intern Med J. 2018 Apr;48(4):488.

PMID:
29224209
22.

A novel Bayesian geospatial method for estimating tuberculosis incidence reveals many missed TB cases in Ethiopia.

Shaweno D, Trauer JM, Denholm JT, McBryde ES.

BMC Infect Dis. 2017 Oct 2;17(1):662. doi: 10.1186/s12879-017-2759-0.

23.

Research ethics committees in the Pacific Islands: gaps and opportunities for health sector strengthening.

Denholm JT, Bissell K, Viney K, Durand AM, Cash HL, Roseveare C, Merilles OE Jr, Harries AD, Biribo S.

Public Health Action. 2017 Mar 21;7(1):6-9. doi: 10.5588/pha.16.0076.

24.

Strategic partnerships towards tuberculosis elimination.

Denholm JT.

Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1072. doi: 10.5588/ijtld.17.0517. No abstract available.

PMID:
28911346
25.

Optimally capturing latency dynamics in models of tuberculosis transmission.

Ragonnet R, Trauer JM, Scott N, Meehan MT, Denholm JT, McBryde ES.

Epidemics. 2017 Dec;21:39-47. doi: 10.1016/j.epidem.2017.06.002. Epub 2017 Jun 16.

26.

A user-friendly mathematical modelling web interface to assist local decision making in the fight against drug-resistant tuberculosis.

Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES.

BMC Infect Dis. 2017 May 30;17(1):374. doi: 10.1186/s12879-017-2478-6.

27.

Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002-2015.

Dale KD, Tay EL, Trauer JM, Trevan PG, Denholm JT.

BMC Infect Dis. 2017 May 3;17(1):324. doi: 10.1186/s12879-017-2421-x.

28.

Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.

Dale KD, Globan M, Tay EL, Trauer JM, Trevan PG, Denholm JT.

Int J Tuberc Lung Dis. 2017 May 1;21(5):550-555. doi: 10.5588/ijtld.16.0651.

PMID:
28399970
29.

Response to: Socio-political prescriptions for latent tuberculosis infection are required to prevent reactivation of tuberculosis.

Fox GJ, Dobler CC, Marais BJ, Denholm JT.

Int J Infect Dis. 2017 May;58:117-118. doi: 10.1016/j.ijid.2017.03.004. Epub 2017 Mar 27.

30.

Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.

Shaweno D, Shaweno T, Trauer JM, Denholm JT, McBryde ES.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):79-85. doi: 10.5588/ijtld.16.0325.

PMID:
28157469
31.

Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.

Ragonnet R, Trauer JM, McBryde ES, Houben RM, Denholm JT, Handel A, Sumner T.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):60-66. doi: 10.5588/ijtld.16.0297.

32.

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES.

BMC Infect Dis. 2017 Jan 6;17(1):36. doi: 10.1186/s12879-016-2171-1.

33.

Preventive therapy for latent tuberculosis infection-the promise and the challenges.

Fox GJ, Dobler CC, Marais BJ, Denholm JT.

Int J Infect Dis. 2017 Mar;56:68-76. doi: 10.1016/j.ijid.2016.11.006. Epub 2016 Nov 18. Review.

34.

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Trauer JM, Achar J, Parpieva N, Khamraev A, Denholm JT, Falzon D, Jaramillo E, Mesic A, du Cros P, McBryde ES.

BMC Med. 2016 Nov 18;14(1):187.

35.

Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.

Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A.

Lancet Glob Health. 2016 Nov;4(11):e816-e826. doi: 10.1016/S2214-109X(16)30265-0. Epub 2016 Oct 6.

36.

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.

Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG.

Lancet Glob Health. 2016 Nov;4(11):e806-e815. doi: 10.1016/S2214-109X(16)30199-1. Epub 2016 Oct 6.

37.

Tuberculosis and the traveller: evaluating and reducing risk through travel consultation.

Denholm JT, Thevarajan I.

J Travel Med. 2016 Mar;23(3). doi: 10.1093/jtm/taw008. Review.

PMID:
27358971
38.

Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.

Trauer JM, Denholm JT, Waseem S, Ragonnet R, McBryde ES.

Am J Epidemiol. 2016 Jun 15;183(12):1138-48. doi: 10.1093/aje/kwv323. Epub 2016 May 19.

PMID:
27199387
39.

Mortality among tuberculosis cases in Victoria, 2002-2013: case fatality and factors associated with death.

Dale K, Tay E, Trevan P, Denholm JT.

Int J Tuberc Lung Dis. 2016 Apr;20(4):515-23. doi: 10.5588/ijtld.15.0659.

PMID:
26970162
40.

Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?

Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES, Denholm JT.

Chest. 2016 Feb;149(2):516-525. doi: 10.1016/j.chest.2015.11.017.

PMID:
26867835
41.

Assessing risk of tuberculosis in international travellers: progress and new challenges.

Denholm JT.

J Travel Med. 2016 Jan 20;23(1). pii: tav001. doi: 10.1093/jtm/tav001. Print 2016 Jan. No abstract available.

PMID:
26792226
42.

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, Anovadiya AP, Araújo WN, Azziz-Baumgartner E, Báez C, Bantar C, Barhoush MM, Bassetti M, Beovic B, Bingisser R, Bonmarin I, Borja-Aburto VH, Cao B, Carratala J, Cuezzo MR, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Fraser J, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hoffmann M, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Khandaker G, Knight M, Kusznierz G, Kuzman I, Kwan AM, Lahlou Amine I, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Manabe T, Mayo-Montero E, McGeer A, Memish ZA, Metan G, Mikić D, Mohn KG, Moradi A, Nymadawa P, Ozbay B, Ozkan M, Parekh D, Paul M, Poeppl W, Polack FP, Rath BA, Rodríguez AH, Siqueira MM, Skręt-Magierło J, Talarek E, Tang JW, Torres A, Törün SH, Tran D, Uyeki TM, van Zwol A, Vaudry W, Velyvyte D, Vidmar T, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2016 May;10(3):192-204. doi: 10.1111/irv.12363. Epub 2016 Feb 1.

43.

Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics.

Ragonnet R, Trauer JM, Denholm JT, Geard NL, Hellard M, McBryde ES.

Sci Rep. 2015 Oct 20;5:15468. doi: 10.1038/srep15468.

44.

In reply. Promoting ethical and evidence-based policies for latent tuberculosis.

Denholm JT, Matteelli A, Reis A.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1258-9. doi: 10.5588/ijtld.15.0302-2. No abstract available.

PMID:
26459544
45.

Evaluation of tuberculin skin testing in tuberculosis contacts in Victoria, Australia, 2005-2013.

Moyo N, Tay EL, Denholm JT.

Public Health Action. 2015 Sep 21;5(3):188-93. doi: 10.5588/pha.15.0018.

46.
47.

Latent tuberculous infection: ethical considerations in formulating public health policy.

Denholm JT, Matteelli A, Reis A.

Int J Tuberc Lung Dis. 2015 Feb;19(2):137-40. doi: 10.5588/ijtld.14.0543.

PMID:
25574909
48.

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study.

Denholm JT, McBryde ES, Eisen DP, Penington JS, Chen C, Street AC.

Drug Healthc Patient Saf. 2014 Oct 20;6:145-9. doi: 10.2147/DHPS.S68837. eCollection 2014.

49.

In reply.

Denholm JT, Amon JJ, O'Brien R, Narain A, Kim SJ, El Sony A, Edginton ME.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1132-3. doi: 10.5588/ijtld.14.0149-2. No abstract available.

PMID:
25189565
50.

Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.

Trauer JM, Denholm JT, McBryde ES.

J Theor Biol. 2014 Oct 7;358:74-84. doi: 10.1016/j.jtbi.2014.05.023. Epub 2014 May 27.

Supplemental Content

Loading ...
Support Center